NSIM
ARNA

North Star Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

North Star Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4
Closed – – 1088
2016
Q4 		$0 Buy
+4
New +$62 ﹤0.01% 994

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

North Star Investment Management's ARNA Position: Q1 2017 in Review

North Star Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2017, closing a stake of 4 shares.

North Star Investment Management first reported a position in ARNA in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 126 funds tracked by Wall St. Rank hold ARNA as of Q1 2017.

  • North Star Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • North Star Investment Management sold 4 Arena Pharmaceuticals Inc shares in Q1 2017.
  • North Star Investment Management first reported a position in Arena Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
  • North Star Investment Management's Arena Pharmaceuticals Inc position peaked at $0 in Q4 2016.
  • 126 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2017.

Based on North Star Investment Management's 13F filing for Q1 2017, filed 28 Apr 2017.